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Abstract. It is recommended that clinical laboratories keep the bias of serum total cholesterol analysis at 
≤3.0% compared to a reference method. In Korea, national cholesterol proficiency testing has long been 
available, but there has been little information about the magnitude of analytical bias. The authors calculated 
the bias of the peer group mean for Korea’s national cholesterol proficiency test through an indirect approach 
that overcomes the potential matrix effect of proficiency test materials. One laboratory was selected among 
the proficiency test participants to represent Korean laboratories. Total cholesterol levels of six fresh serums 
spanning a wide range of concentrations were measured by the representative laboratory and three reference 
laboratories. The relationship between the proficiency test mean and the reference method mean was 
established by linear regression analysis. The peer group mean of the proficiency test was calculated to have 
a bias of +2.4 to +2.5% at the medical decision levels. When grouped by instrument and reagent, 29 to 66% 
of the laboratories showed biases <3.0%. Thus it was determined that the peer group mean of the Korean 
cholesterol proficiency test has an acceptable level of positive bias. The indirect approach used in this study 
provides a practical model for estimating cholesterol analytical bias for proficiency testing. 
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Introduction
In clinical laboratories, the accuracy of serum total 
cholesterol measurements has been regarded as 
especially important, because a laboratory result 
itself is directly used for determining the cardio-
vascular risk of an individual [1-4]. Therefore, every 
laboratory should have accurate, reproducible 
cholesterol measurements, enabling sound medical 
practice. To achieve that goal, authorized guidelines 
have been issued for clinical laboratories; prominent 
among these are recommendations of the Laboratory 
Standardization Panel (LSP) of the National Chole-
sterol Education Program (NCEP) [5]. This panel 
recommends that clinical laboratories achieve a 
bias of ≤3.0% compared to the Centers for Disease 
Control and Prevention (CDC) reference method 
and overall precision consistent with a CV of ≤3.0% 
[5]. Although these recommendations originated in 
the United States,  they have been accepted world-
wide, because the CDC is connected to the World 
Health Organization Collaborating Center for 
Reference and Research in Blood Lipids. 
 In Korea, the national proficiency test program 
that is provided by the Korean Association of 
Quality Assurance for Clinical Laboratories 
(KAQACL) plays a critical role for inter-institutional 
harmonization of cholesterol measurements. In 
2007, more than 700 laboratories participated in 
the KAQACL serum cholesterol proficiency test 
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[6]. According to the report of the KAQACL, about 
99% of the participating laboratories used an 
enzymatic method for measuring serum cholesterol 
concentration and were grouped together as one 
peer [6-8]. These laboratories were encouraged to 
adjust their cholesterol results to agree with the 
peer group mean obtained from the proficiency 
materials. However, bias of the peer group mean 
was not assessed properly; hence,  improvement in 
the accuracy of cholesterol measurement was 
limited. Although it is desirable for practicing 
evidence-based medicine, the bias of the peer group 
mean has not been measured reliably prior to this 
study. As the degree of inter-laboratory agreement 
has become progressively higher, the demand for 
estimating the bias of the peer group mean has 
become more and more apparent. 
 The CDC uses the Abel-Kendall version of the 
Liebermann-Buchard procedure as the reference 
method for total cholesterol measurement [9]. In 
addition, the CDC has approved several laboratories 
worldwide to perform the Abel-Kendall method 
for certifying the commercial cholesterol assay kits 
produced by manufacturers. This group of 
laboratories is known as the Cholesterol Reference 
Method Laboratory Network (CRMLN) [9,10]. 
There were nine CRMLN laboratories spanning 
the United States, Europe, Asia, Canada, and 
South America at the time of this study [11]. It is 
deemed inappropriate to apply the Abel-Kendall 
method directly to the KAQACL proficiency test 
materials, because commercial proficiency materials 
are treated with stability-enhancing processes and 
they may not produce accurate results with the 
reference method due to matrix bias [12]. According 
to the laboratory certification protocol issued by 
CRMLN, any serum preservation method apart 
from freezing is unacceptable for the Abel-Kendall 
method [10]. Therefore, estimating the bias of the 
KAQACL proficiency test program required a 
scheme different from direct measurement. 
 Given that background, we adopted an indirect 
approach by selecting a representative Korean 
laboratory to serve as an intermediary to correlate 
the reference method and the peer group means of 
the proficiency test. Through this indirect approach, 
we estimated the bias and degree of compliance of 
Korean laboratories to the LSP recommendations.
Materials and Methods
Selection of a representative laboratory. Through searching 
the database of the KAQACL proficiency test in 2007 and 
personal interviews, we selected a laboratory whose proficiency 
test result was close to the peer group mean. Compared to the 
peer group means, the laboratory showed a correlation 
coefficient of 0.999 and an average difference of -0.1% (Table 
1). Due to such a high degree of agreement with the peer 
group mean, the representative laboratory did not adjust its 
calibration, thus deviating from the routine practice up to the 
time of this study. The representative laboratory used Liquid 
Calibrator (Denka-Seiken Co., Tokyo, Japan), Determiner- 
C-TC reagent (Kyowa-Medex Co., Tokyo, Japan), and a 
TBA-200FR analyzer (Toshiba Medical Systems Co., Tochigi-
Ken, Japan) to measure total cholesterol concentrations. 
Specimen collection and transportation. Cholesterol measure-
ments followed the Certification Protocol for Clinical Labor-
atories of CRMLN as far as possible [10]. All serum specimens 
were stored at 2 to 8°C within 8 hr from the time of veni-
puncture [10]. Six serum cholesterol levels were prepared. 
Two were between 100 and 200 mg/dl, two were between 
200 and 240 mg/dl, and the rest were >240 mg/dl. The volume 
of each serum specimen exceeded 9 ml. The difference of the 
cholesterol concentrations between neighboring levels was 
>20 mg/dl and that between the highest and the lowest was 
>100 mg/dl [10]. Because sufficient serum could not be 
obtained from single individuals at all the levels, serums from 
Table 1. Comparison between the peer group mean and the 
result of the representative laboratory of the KAQACL 
cholesterol proficiency test in 2007.
 
 Peer group* Representative  
 mean (n = 746) laboratory
Sample 1 (mg/dl) 246 242
Sample 2 (mg/dl) 236 231
Sample 3 (mg/dl) 125 125
Sample 4 (mg/dl) 236 233
Sample 5 (mg/dl) 100 100
Sample 6 (mg/dl) 100 100
Sample 7 (mg/dl) 261 261
Sample 8 (mg/dl) 104 108
Sample 9 (mg/dl) 105 106
Sample 10 (mg/dl) 260 260
Sample 11 (mg/dl) 265 257
Sample 12 (mg/dl) 106 107
Mean (mg/dl) 178.7 177.5
Corr. coefficient (r2) with peer group mean: 0.999
Mean difference from peer group mean (%):   -0.1
Mean of absolute difference from 
 peer group mean (%);     1.2
* The peer group consisted of 99% of all laboratories using 
enzymatic methods.
































































































































































































































































































































































































































two persons were pooled for the highest two concentrations as allowed by 
CRMLN [10]. Three aliquots were made to contain 1 ml of each serum 
specimen. These aliquots were kept refrigerated until the time of cholesterol 
measurement by the representative laboratory. Three additional aliquots 
containing 2 ml of each serum specimen were prepared and each aliquot was 
sent to the three CRMLN laboratories, which were (i) the Northwest Lipid 
Metabolism and Diabetes Research Laboratories of University of Washington 
(Seattle, WA, USA), (ii) Diagnostica e Ricerca S. Raffaele (Milan, Italy), and 
(iii) the Lipid Reference Laboratory of Osaka Medical Center for Health 
Science and Promotion (Osaka, Japan). During transport to the CRMLN 
laboratories, the specimens were kept frozen at < -20°C. 
Total cholesterol measurement. The representative laboratory measured the 
cholesterol concentrations of all six specimens twice a day consecutively for 3 
days, from the day following venipuncture. For every level, one aliquot was 
used on each  day of measurement. During the study, routine maintenance of 
the analyzer, calibration, and internal quality control was done. The model of 
the analyzer and the reagent brand were the same as those in the 2007 
KAQACL proficiency test. 
 Each CRLMN laboratory measured the total cholesterol levels of the six 
specimens repeatedly by the Abel-Kendall method. Once 0.5 ml of a serum 
specimen was saponified with 5.0 ml of 0.36 mol/L ethanolic KOH at 50°C 
for 60 min, 10 ml of hexane was added for extraction. After removing water 
from the extract, 3.2 ml of Liebermann-Buchard reagent was added. 
Absorbance was measured at 620 nm after 30 min of incubation [13]. To 
minimize the effect of a possible random error, one CRMLN laboratory ran 
the specimens in quadruplicate, while the other laboratories ran the specimens 
in duplicate as recommended for the usual certification of assays for a clinical 
laboratory [10].
Statistical analysis. Traceability was determined by the CDC criteria [14]. 
Linear regression analysis was used for comparisons between the reference 
method mean, the representative laboratory mean, and the peer group mean 
of the KAQACL proficiency test. First, the representative laboratory mean was 
correlated with the reference method mean and the peer group mean, 
respectively. Then, the peer group mean was correlated with the reference 
method mean, using the representative laboratory mean as an intermediary. 
Based on the regression equation between the reference method mean and the 
peer group mean, a reference method concentration of each proficiency 
material was calculated. Then, the calculated reference method concentration 
was compared against the proficiency test result of an individual laboratory or 




Measurement of total cholesterol. Total cholesterol concentrations 
of the six fresh serum specimens measured by the representative 
laboratory and the 3 CRMLN reference laboratories are listed in 
Table 2. The cholesterol concentrations measured by each 
reference laboratory differed by <1.0% from the mean concen-
trations of all three reference laboratories. That was judged to be 
acceptable, considering the limit of bias applied to CRMLN 
laboratories [14]. Also, the representative laboratory was found to 
fulfill the traceability criteria of the CDC having a mean bias of 
+1.3%.
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Table 3. Calculated bias of the cholesterol proficiency test result of a group of laboratories using the same model of analyzer.
Instrument No. Linear regression of the  Linear regression of the Bias Bias  Proportion of
model of proficiency test result   group’s proficiency test at at proficiency test
  labs. between the group and  result and the calculated 200 240 results with a
   the representative laboratory*  reference interval mg/dl mg/dl bias ≤3.0%
      concentration† (%) (%) 
   Regression formula r
Hitachi 7180 43 y = 1.012x - 2.328 1.000 y = 0.983x + 5.726   1.1  0.7 275/468 (58.8%)
Olympus AU400 38 y = 1.077x - 10.548 0.999 y = 0.924x + 13.016 -1.1 -2.2 188/459 (41.0%)
Hitachi 7060 37 y = 1.014x + 0.772 1.000 y = 0.982x + 2.659 -0.5 -0.8 188/444 (42.3%)
Olympus AU640 35 y = 1.053x - 6.981 0.999 y = 0.945x + 9.923 -0.6 -1.4 186/417 (44.6%)
Hitachi 7080 34 y = 1.014x +0.073 1.000 y = 0.981x + 3.347 -0.2 -0.5 173/396 (43.7%)
Toshiba TBA-200FR 29 y = 1.000x - 0.945 1.000 y = 0.995x + 4.414   1.7  1.4  187/330 (56.7%)
Roche Modular D/P 23 y = 1.032x - 7.433 1.000 y = 0.964x + 10.565   1.7  0.8 176/273 (64.5%)
Siemens Advia 1650 15 y = 1.016x - 7.438 1.000 y = 0.979x +10.736   3.3  2.4  111/176 (63.1%)
*The variable ‘x’ is the proficiency test result of the representative laboratory and the variable ‘y’ is the proficiency test mean of 
the group of laboratories using the same model of analyzer.
†The variable ‘x’ is the calculated reference concentration, and the variable ‘y’ is the proficiency test mean of the group of 
laboratories using the same model of analyzer.
Table 4. Calculated bias of the cholesterol proficiency test result of a group of laboratories using the same brand of reagent.
Reagent No. Linear regression of the  Linear regression of the Bias Bias  Proportion of 
brand of proficiency test result   group’s proficiency test at at proficiency test
  labs. between the group and  result and the calculated 200 240 results with a
   the representative laboratory*  reference interval mg/dl mg/dl bias ≤3.0%
      concentration† (%) (%) 
   Regression formula r
Daiichi Preauto S 112 y = 1.014x - 2.291 1.000 y = 0.982x + 5.682   1.0  0.5 701/1317 (53.2%)
Wako CHO   68 y = 1.014x + 1.817 1.000 y = 0.981x + 1.628 -1.1 -1.2 235/804 (29.2%)
Olympus OSR  63 y = 1.017x - 4.652 0.997 y = 0.978x + 7.985   1.8   1.2 340/763 (44.6%)
Asan 701 LQ DIA  59 y = 1.014x - 0.575 1.000 y = 0.981x + 3.987   0.1 -0.2 366/720 (50.8%)
Shinyang SICDIA  53 y = 0.988x + 1.482 1.000 y = 1.001x + 2.010   1.7   1.6 388/658 (59.0%)
DiaSys Cholesterol  48 y = 1.053x - 6.927 0.999 y = 0.945x + 9.870 -0.6 -1.4 204/551 (37.0%)
Roche CHOD-PAP  33 y = 1.039x - 8.781 1.000 y = 0.9575x + 11.790   1.6  0.7 246/372 (66.1%)
*The variable ‘x’ is the proficiency test result of the representative laboratory and the variable ‘y’ is the proficiency test mean of 
the group of laboratories using the same brand of reagent.
†The variable ‘x’ is the predicted reference concentration and the variable ‘y’ is the proficiency test mean of the group of laboratories 
using the same brand of reagent.
Annals of Clinical & Laboratory Science, vol. 40, no. 1, 201056
Correlation between the KAQACL proficiency test 
and the reference method. The correlation coefficient 
and the standard error of the estimate between the 
results of the representative laboratory and the 
reference method mean were 0.999 and 3.8 mg/dl, 
respectively (Fig. 1B). Based on this correlation, the 
relationship between the peer group means of the 
KAQACL proficiency test and the reference method 
mean could be plotted, and the standard error of 
the estimate was 4.3 mg/dl (Fig. 1C). Based on the 
plot, it was predicted that the KAQACL proficiency 
test had biases of +2.4 and +2.5% at the medical 
decision levels of 200 mg/dl and 240 mg/dl, 
respectively. 
 Among the 12 trials of the proficiency test 
using different materials, a trial with the mean 
concentration close to the medical decision level 
was chosen to show a typical distribution of the 
results (Fig. 2). The peer group mean was estimated 
to have a positive bias of 2.5% referenced to the 
calculated reference concentration. Among the 686 
participating laboratories, 59.2% reported a result 
<3.0% different from the peer group mean. 
However, only 49.9% were found to have a predicted 
bias  of ≤3.0%. This finding was partly caused by 
the high proportion of the results clustered around 
the peer group mean.
 For major groups of laboratories using the same 
model of analyzer and the same reagent, the 
proportion of results with predicted bias of ≤3.0% 
is shown inTable 3 and Table 4. The proportions 
were remarkably variable, ranging from 29.2% and 
66.1%. All but one of the groups had predicted 
biases ≤3.0% at the medical decision levels.
Fig. 1. This chart shows the x-y 
plots and linear regression lines 
for cholesterol means analyzed 
by the representative laboratory, 
the peer group of the proficiency 
test, and the reference Abel-
Kendall method. Note that plot 
(C) contains statistically defined 
95% confidence limits but no 
data points, because the linear 
regression line was drawn by 
indirect analysis by way of the 
representative laboratory.
Bias of the Korean national cholesterol proficiency test 57
Discussion
Each clinical laboratory should maintain a bias of 
cholesterol measurement within the globally 
recommended limit of 3.0% [5]. A long-standing 
national proficiency testing program has helped to 
reduce inter-laboratory differences of cholesterol 
assays in Korean laboratories. However, to enhance 
the significance of inter-laboratory harmonization, 
it was necessary to determine the bias of the peer 
group mean. Because the KAQACL materials were 
lyophilized commercial products, the authors had 
to develop an indirect approach to estimate the bias 
of the proficiency test samples. For a simpler 
procedure, fresh frozen sera could have been used 
for the proficiency test. But in that case, pooling 
multiple sera would have been necessary for 
distribution to a large number of laboratories, and 
that would have complicated comparison with the 
reference method [9,15]. Even if it were possible to 
obtain sufficient serum from a single individual to 
cover both the reference method and proficiency 
test, that would be feasible only for a limited range 
of concentrations [16]. Therefore direct comparison 
between the KAQACL proficiency test and the 
reference method was considered to be an unrealistic 
option for estimating the bias. 
 Ross et al. [12] showed the existence of the 
matrix effect, which results in a different behavior 
of a proficiency test material compared to that of 
fresh serum. Based on that finding, we used an 
indirect method to compare the reference method 
mean and the peer group mean of the proficiency 
test. Through this indirect approach, it was possible 
to assess the degree of compliance of Korean 
laboratories to the LSP recommendation for bias.
Fig. 2. Distribution of cholesterol concentration of a selected trial of the proficiency test. The peer group mean was estimated to 
have a positive bias of 2.5%. A dotted square was drawn to delineate the proficiency test results having a bias of 3.0% or less.
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 Through the correlation between the peer 
group mean and the reference method mean, it was 
found that the bias of the peer group mean at the 
medical decision level was <3.0%, which was 
regarded as acceptable in respect to the LSP 
recommendation. However, considering that the 
proficiency test results tended to cluster around the 
biased peer group mean, further efforts were 
deemed necessary to reduce the bias. In addition, 
the distribution of the proficiency test results was 
skewed, having predominantly positive biases. That 
finding suggests that the prevalence of hyperchol-
esterolemia in Koreans could be over-estimated. 
Although further investigation seemed necessary 
before reaching a definite conclusion, it was 
envisioned that reducing the bias of cholesterol 
measurements in Korean clinical laboratories might 
change the current epidemiological data.
 Grouping laboratories according to the analyzer 
and the brand of reagent revealed that variable 
proportions of each group showed a bias of ≤3.0% 
at the medical decision levels. Remarkably, the 
group of users of Advia 1650 (Siemens Medical 
Solutions Diagnostics, Deerfield, IL, USA) showed 
a mean bias >3.0% at 200 mg/dl, although the 
analyzer itself had been certified by CRMLN [17]. 
On the other hand, users of Wako CHO (Wako 
Pure Chemical Industries, Osaka, Japan) showed 
the lowest proportion of results with bias <3.0%, 
although the reagent itself was certified by CRMLN 
[17]. Users of reagents without CRMLN 
certification, Asan 701 LQ DIA, (Asan Pharma-
ceutical, Seoul, Korea) and Shinyang SICDIA 
(Shinyang Chemical, Seoul, Korea) had relatively 
higher proportions of bias <3.0%. Based on these 
findings, the bias of an individual clinical laboratory 
was affected by the quality of laboratory practice.
 Considering that most peer group means of 
the proficiency test were estimated to be <3.0%, it 
was assumed that the proficiency test had improved 
accuracy as well as laboratory harmonization. 
However, the analysis also revealed that almost 
half of the proficiency test results demonstrated less 
than acceptable bias. Such an unsatisfactory level 
of compliance was thought to warrant heightened 
awareness of inaccuracy and further efforts to be 
exerted by the relevant academic societies. 
 For an individual laboratory, an acceptable bias 
should be combined with a satisfactory level of 
precision to achieve accuracy of cholesterol 
measurement. In future investigations, information 
about bias, estimated by the method described in 
this study, can be supplemented by the laboratory’s 
own internal quality control data. That will allow a 
better estimate of the impact of the bias on the 
diagnosis and treatment of hypercholesterolemia 
and on the disease prevalence among Koreans. 
 In conclusion, we estimated the bias of the peer 
group mean of the Korean cholesterol proficiency 
test using an indirect approach. The strategy 
employed in this study can serve as a model for 
determining the bias of proficiency tests for other 
analytes as well. The peer group mean of the 
KAQACL cholesterol proficiency test was shown to 
have mostly positive biases <3.0%.
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